Pharma Danckaert SPRL
0.8 FTEThe score of Pharma Danckaert shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -56 % Total assets +6 % Headcount (avg FTE) -56 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma Danckaert's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 09 Jun 2026
- Year ended 31 Dec 2024filed on 17 Jul 2025
- Year ended 31 Dec 2023filed on 03 Jul 2024
- Year ended 31 Dec 2022filed on 29 Jun 2023
- Year ended 31 Dec 2021filed on 30 Jun 2022
Pharma Danckaert's financial analysis
- Solvency26.4%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma Danckaert
Pharma Danckaert's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0418.267.166
- VAT number
- BE0418267166
- Peppol
- Registered · 0208:0418267166 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 19 Apr 1978
- Registered office
- 2100 Antwerp
- Size
- Micro · 0.8 FTE
- Latest accounts
- 2025 · filed on 09 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharma Danckaert (SPRL) has been based in Antwerp since 1978, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 8,462 € and equity of 34,866 €; its revenue is not published. With 0.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 26.4%, below the median of its sector (44.2%).
Companies similar to Pharma Danckaert
Companies in the same business, of comparable size and area, outside its group.
- Commuphar Retail sale of pharmaceutical products Antwerp · balance sheet 136,781 €
- Pharmacie VERHEYDEN Retail sale of pharmaceutical products Brussels · balance sheet 135,673 €
- Medlinx Lina Retail sale of pharmaceutical products Schaerbeek · balance sheet 130,245 €
- O.Sabur Retail sale of pharmaceutical products Genk · balance sheet 129,423 €
- Sirona Pharma Retail sale of pharmaceutical products Etterbeek · balance sheet 138,027 €
- Apotheker Bosmans Kristien Retail sale of pharmaceutical products Merchtem · balance sheet 138,175 €
- Mont Royal Retail sale of pharmaceutical products Brussels · balance sheet 126,135 €
- Pharmacentre Retail sale of pharmaceutical products Wavre · balance sheet 138,900 €
Frequently asked questions about Pharma Danckaert
What is the revenue of Pharma Danckaert?
Pharma Danckaert files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma Danckaert?
In Belgium, the VAT number is the company number prefixed with BE: BE0418267166 for Pharma Danckaert, if the company is VAT-registered. Its company number (CBE) is 0418.267.166.
Where is the registered office of Pharma Danckaert?
According to the CBE register, the registered office of Pharma Danckaert is in 2100 Antwerp.
What is the equity of Pharma Danckaert?
At the close of the 2025 financial year, the equity of Pharma Danckaert amounts to 34,866 €, a solvency of 26.4% of total assets.
How many people work at Pharma Danckaert?
0.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharma Danckaert?
The register lists 4 active mandates at Pharma Danckaert. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharma Danckaert
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →